Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools today ...

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and ...

Based on current trends, the shares are expected to debut at the upper price band of Rs 321. Note: GMP does not present official data and is based on speculation. Following the finalisation of IPO ...